Verrica Pharmaceuticals VRCA
NASDAQ VRCA
$4.38 -0.13 (-2.88%)
At close: Oct 2, 2026 · 4:00 PM EDT

Verrica Pharmaceuticals (VRCA) Cash & Current Investments (2017 - 2026)

Updated

Verrica Pharmaceuticals (VRCA) reported Cash & Current Investments of $11.2 million for Q2 2026, down 27.3% from $15.4 million a year earlier and down 45.6% from the prior quarter.

Analysis

Verrica Pharmaceuticals (VRCA) Cash & Current Investments (2017 - 2026) Analysis & Trends

At the end of FY2025, Verrica Pharmaceuticals posted Cash & Current Investments of $30.15 million, down 34.9% from FY2024.

  • Cash & Current Investments has a five-year compound annual growth rate of 23.1% (FY2020 to FY2025).
  • By year, Cash & Current Investments came in at $46.33 million in FY2024 (-33.4%), $69.55 million in FY2023 (+102.9%), $34.27 million in FY2022 (+117.6%) and $15.75 million in FY2021 (+47.4%).
  • The Q2 2026 figure ranks as the lowest quarterly Cash & Current Investments since Q4 2020.
  • Year over year, Cash & Current Investments has now declined in each of the last ten quarters, with an average decline of 37.3% over the last eight quarters.
  • The high point for year-over-year Cash & Current Investments in five years was Q3 2023 (growth of 159.6%); the low point was Q3 2024 (a decline of 72.7%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $20.6 million (Q1 2026), $30.15 million (Q4 2025) and $21.1 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 20.76 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 6.57 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 9.92 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 4.97 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 3.18 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.70 Bn
10 Verrica Pharmaceuticals 75.24 Mn -7.80 Mn - 11.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 11.20 Mn
Mar 31, 2026 20.60 Mn
Dec 31, 2025 30.15 Mn
Sep 30, 2025 21.10 Mn
Jun 30, 2025 15.40 Mn
Mar 31, 2025 29.60 Mn
Dec 31, 2024 46.33 Mn
Sep 30, 2024 23.00 Mn
Jun 30, 2024 31.93 Mn
Mar 31, 2024 48.94 Mn
Dec 31, 2023 69.55 Mn
Sep 30, 2023 84.31 Mn
Jun 30, 2023 55.14 Mn
Mar 31, 2023 60.00 Mn
Dec 31, 2022 34.27 Mn
Sep 30, 2022 32.47 Mn
Jun 30, 2022 45.43 Mn
Mar 31, 2022 50.41 Mn
Dec 31, 2021 15.75 Mn
Sep 30, 2021 20.44 Mn
API Access

Verrica Pharmaceuticals Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=VRCA&period=max&api_key=YOUR_API_KEY